Cleared Traditional

K880062 - C-MATE #CMU 1001

K880062 is an FDA 510(k) clearance for C-MATE #CMU 1001, manufactured by O.R. Specialties, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K880062 · O.R. Specialties, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1988
Decision
60d
Days
Class 2
Risk

K880062 is an FDA 510(k) clearance for the C-MATE #CMU 1001. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by O.R. Specialties, Inc. (Tuscaloosa, US). The FDA issued a Cleared decision on March 7, 1988 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all O.R. Specialties, Inc. devices

FDA 510(k) Submission Details - K880062

510(k) Number K880062 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 07, 1988
Decision Date March 07, 1988
Days to Decision 60 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 110d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 198
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K880062.
SITE MACROBORE PHACO NEEDLE
K883099 · Site Microsurgical Systems, Inc. · Sep 1988
MODIFICATION TO THE SITE PERISTALTIC MODULE SYSTEM
K883199 · Chiron Vision Corp. · Sep 1988
SITE ULTRASONIC I/A PHACO NEEDLE
K882103 · Site Microsurgical Systems, Inc. · Jul 1988
IN-LINE OPHTHALMIC IRRIGATING SOLUTION FILTERS
K871854 · CooperVision, Inc. · Jul 1987
SITE PHACOEMULSIFICATION SYSTEM/OPHTHALMIC USE
K871485 · Site Microsurgical Systems, Inc. · Jun 1987
I/A/KPE TIP
K864726 · Ipax, Inc. · Jan 1987